Irradiation-induced IFN-type-I pathway activation in prostate cancer cell lines

被引：3
作者：
Xanthopoulou, Erasmia T. [1 ]
Koukourakis, Ioannis M. [2 ]
Kakouratos, Christos [1 ]
Nanos, Christos [1 ]
Kalaitzis, Christos [3 ]
Giatromanolaki, Alexandra [4 ]
Koukourakis, Michael I. [1 ]
机构：
[1] Democritus Univ Thrace, Dept Radiotherapy Oncol, POB 12, Alexandroupolis 68100, Greece
[2] Aretaie Univ Hosp, Neonatol Unit, Athens, Greece
[3] Democritus Univ Thrace, Dept Urol, Alexandroupolis 68100, Greece
[4] Democritus Univ Thrace, Dept Pathol, Alaxandroupolis 68100, Greece
来源：
CYTOKINE | 2023年 / 169卷
关键词：
Prostate cancer; Radiotherapy; Type-I Interferon Pathway; IFN-stimulated genes; RADIOTHERAPY; INTERFERON;
D O I：
10.1016/j.cyto.2023.156252
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The Interferon (CYRILLIC CAPITAL LETTER BYELORUSSIAN-UKRAINIAN IFN) Type-I pathway has an important role in the activation of an anti-tumor immune response. We investigated the effects of two different dose fractionations of radiation (3 daily 8 Gy fractions vs. one fraction of 20 Gy) on the activation of the Type-I IFN-pathway in three hormone-dependent (22Rv1) and independent (DU145, PC3), prostate cancer (PC) cell lines. Regardless of the dose schedules, radiation-induced the expression of IFN-stimulated genes in all PC cell lines, with a strong up-regulation of the IFI6v2 and IFI44 genes. In addition, strong up-regulation of the MX1 and MX2 genes was noted in the PC3 cell line. This effect was independent of the expression of IFN & beta;, cGAS, or TREX1 levels. It is suggested that the RT-induced IFN type-I response could be exploited for the development of immuno-RT policies for localized and metastatic PC.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines
    Laura Lattanzio
    Federica Tonissi
    Martino Monteverde
    Daniela Vivenza
    Elvio Russi
    Gérard Milano
    Marco Merlano
    Cristiana Lo Nigro
    Investigational New Drugs, 2015, 33 : 310 - 320
  • [32] Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines
    Lattanzio, Laura
    Tonissi, Federica
    Monteverde, Martino
    Vivenza, Daniela
    Russi, Elvio
    Milano, Gerard
    Merlano, Marco
    Lo Nigro, Cristiana
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (02) : 310 - 320
  • [33] SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines
    Choi, So Young
    Jeon, Ju Mi
    Na, Ann Yae
    Kwon, Oh Kwang
    Bang, In Hyuk
    Ha, Yun-Sok
    Bae, Eun Ju
    Park, Byung-Hyun
    Lee, Eun Hye
    Kwon, Tae Gyun
    Lee, Jun Nyung
    Lee, Sangkyu
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (01) : 50 - 59
  • [34] Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines
    Pinar Obakan
    Elif Damla Arisan
    Annarica Calcabrini
    Enzo Agostinelli
    Şehnaz Bolkent
    Narçin Palavan-Unsal
    Amino Acids, 2014, 46 : 553 - 564
  • [35] Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines
    Obakan, Pinar
    Arisan, Elif Damla
    Calcabrini, Annarica
    Agostinelli, Enzo
    Bolkent, Sehnaz
    Palavan-Unsal, Narcin
    AMINO ACIDS, 2014, 46 (03) : 553 - 564
  • [36] FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell
    Tao, Yan
    Liu, Shanhui
    Lu, Jianzhong
    Fu, Shengjun
    Li, Lanlan
    Zhang, Jing
    Wang, Zhiping
    Hong, Mei
    BMC UROLOGY, 2022, 22 (01)
  • [37] FOXO3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell
    Yan Tao
    Shanhui Liu
    Jianzhong Lu
    Shengjun Fu
    Lanlan Li
    Jing Zhang
    Zhiping Wang
    Mei Hong
    BMC Urology, 22
  • [38] Anticancer effects of cannabinoid type 2 receptor agonist JWH133 on Prostate Cancer cell lines
    Ozcan, Seda Sabah
    Yapar, Rehime
    Degerli, Ismail
    Elmas, Levent
    Korkmaz, Mehmet
    Cakir, Murat
    ACTA PHYSIOLOGICA, 2025, 241 : 69 - 69
  • [39] IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
    Sarah L. Carter
    Margaret M. Centenera
    Wayne D. Tilley
    Luke A. Selth
    Lisa M. Butler
    BMC Cancer, 16
  • [40] IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
    Carter, Sarah L.
    Centenera, Margaret M.
    Tilley, Wayne D.
    Selth, Luke A.
    Butler, Lisa M.
    BMC CANCER, 2016, 16
12345